Virtual Pitch Day
Genetic Based Application to Address Covid-19 Pandemic
Live webinar with Rehan Huda,
CEO of Greensky Labs
Thursday, April 16, 2020
Green Sky Labs Inc. is a Canadian-based technology incubation company that has funded and developed biotech and medtech subsidiary companies that are now being commercialized. In collaboration with IBM and The DNA Company, Green Sky Labs is building a web-based platform that would identify the risk levels of individuals through their genetic profile for developing complications related to COVID-19. By combining leading edge genetics analytics with artificial intelligence and machine learning, this platform will offer an immediate as well as a long term solution on how to protect a population from pandemics such as COVID-19. This platform was fast tracked in Canada to obtain a Class 1 Medical Device Establishment License and a similar process in now underway for the United States.
Rehan Huda is the Chief Executive Officer of Green Sky Labs Inc. He has over 25 years of experience in investment banking, entrepreneurship and public policy. Mr. Huda has helped fund and structure a number of companies in the education, biotechnology and information technology space. He has served on a number of corporate boards in the private, public and non-profit sectors and has been a guest speaker on finance and leadership at a variety of forums in Canada and globally.
Prior to his career in the private sector, Mr. Huda held various positions within the Canadian federal government including Senior Economist for the Department of Finance and Senior Analyst for the Natural Resources and Industry Departments. He was a recipient of the Government of Canada’s Merit Award for an exceptional and distinguished contribution to the effectiveness and efficiency of the Public Service.